RI
RIKEN
NPWako JPFounded 19173,000 employees
Private CapacadPrivateOncologyGenetic Medicine
Platform: Research Inst
Market Cap
N/A
All Drugs
7
Clinical Trials
7
Failed / Terminated
2
FDA Approved
0
Drug Pipeline (7 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| RIK-IIT-812 | RIK-IIT-812 | Phase 2 | 1 | USP1 | Celiac | ||
| RIK-IIT-635 | RIK-IIT-635 | NDA/BLA | 1 | IL-23 | RCC | ||
| RIK-IIT-829 | RIK-IIT-829 | Phase 3 | 1 | CFTR | MS | ||
| RIK-IIT-251 | RIK-IIT-251 | Phase 1/2 | 1 | USP1 | HS | ||
| RIK-IIT-592 | RIK-IIT-592 | Phase 1/2 | 1 | MDM2 | Parkinson's | ||
| RIK-IIT-658 | RIK-IIT-658 | Phase 3 | 1 | C5 | FL | ||
| RIK-IIT-299 | RIK-IIT-299 | Preclinical | 1 | SHP2 | Bladder Ca |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (6)